This message was sent to ##Email##
|
|
|
|
It's not too late to submit an award nomination! The deadline for AANN and ABNN awards has been extended to Friday, November 8th.
Submit an AANN nomination at www.AANN.org/awards.
Submit your nomination for ABNN Certificant of the Year at http://abnncertification.org/awards.
 The AANN Clinical Practice Guidelines (CPGs) are a key element to help AANN achieve its mission to be the leading authority in neuroscience nursing, inspire passion in nurses, and create the future for the specialty. AANN is currently recruiting volunteers for two roles on the CPG Editorial Board:
- CPG Co-Editor: The Co-Editor will work with the CPG Editor to lead the CPG Editorial Board in following established policies and procedures for creating or updating clinical practice guidelines and evidence-based reviews. The candidate selected for this position will serve a one-year term as Co-Editor (Jan-Dec 2020) and assume the CPG Editor role in January 2021. The CPG Editor is appointed for a three-year term, reviewed annually by the AANN Board of Directors.
- Clinical Practice Guideline (CPG) Editorial Board Members: Editorial Board members serve as a working group to establish goals, direction, and policy recommendations for AANN's Clinical Practice Guidelines Series. Editorial Board members are recommended by the Editor and appointed by the AANN President for a 3 year term.
More information on each volunteer opportunity is available through the "Volunteer" page on the NeuroNetwork. Applications are due Friday, Nov. 15. Please send any questions to Anne Gramiak at agramiak@aann.org.
AANN is partnering with the Association of Rehabilitation Nurses (ARN) to bring you rehab nursing education and resources! AANN members receive 15% off select products using promotional code AANN15 in the ARN online store!
|
Promoted by
|
|
|
|
 |
| Location |
Job Title |
More Information |
Albuquerque, NM
|
Neuroscience ICU RN
|
More info |
Coeur d'Alene, ID
|
Ortho/Neuro Nurse Manager
|
More info |
Urbana, IL
|
Neuro Critical Care APP Position
|
More info |
|
|
| |
Missed an issue of the AANN Neuroscience News? Visit and search the archive today. |
STAT
Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, potentially shaking up the field after years of clinical failures involving experimental therapies from major drug companies. The announcement over the weekend has been met with caution as well as an eagerness from clinicians and others to see full data from the drug maker, Shanghai Green Valley Pharmaceuticals.
READ MORE
University of California - Los Angeles via ScienceDaily
Post-traumatic stress disorder in U.S. military members frequently follows a concussion-like brain injury. Until now, it has been unclear why. A team of psychologists and neurologists reports that a traumatic brain injury causes changes in a brain region called the amygdala, and the brain processes fear differently after such an injury.
READ MORE
|
Promoted by
|
|
|
|
 |
Labiotech
A technique combining a blood test with artificial intelligence, developed by the UK company ClinSpec Diagnostics, could help to prioritize which patients need to be scanned for brain cancer.
A team led by researchers at the University of Strathclyde and the University of Edinburgh, UK, trialed the technology on blood samples from 400 people suspected of having brain tumors. The researchers used an existing technique called infrared spectroscopy to screen 20,000 chemicals in their blood, and then used AI to identify the chemicals that signal a brain tumor. The test correctly identified 82 percent of the patients that would go on to be diagnosed with brain cancer.
READ MORE
Technology Networks
Teams of researchers from Charité - Universitätsmedizin Berlin and the Medical University of Innsbruck have developed a new therapeutic concept for the treatment of temporal lobe epilepsy. It represents a gene therapy capable of suppressing seizures at their site of origin on demand. Having been shown to be effective in an animal model, the new method will now be optimized for clinical use. Results from this research have been published in EMBO Molecular Medicine.
READ MORE
|
|
Science Magazine
In 2016, a 73-year-old woman from Medellín, Colombia, flew to Boston so researchers could scan her brain, analyze her blood, and pore over her genome. She carried a genetic mutation that had caused many in her family to develop dementia in middle age. But for decades, she had avoided the disease. The researchers now report that another rare mutation — this one in the well-known Alzheimer’s disease risk gene APOE — may have protected her. They can’t prove this mutation alone staved off disease. But the study draws new attention to the possibility of preventing or treating Alzheimer’s by targeting APOE — an idea some researchers say has spent too long on the sidelines.
READ MORE
Clinical Pain Advisor
According to study results published in Headache, mindfulness-based cognitive therapy might effectively reduce headache-related disability and attack-level migraine-related disability in people with episodic or chronic migraine.
READ MORE
 |
|
Discover an innovative, remote-based tele-EEG solution that delivers real-time monitoring and reading services for your hospital or private practice. MORE
|
|
NIH
Misfolded protein aggregates are found in the brains of people with many neurodegenerative diseases, but exactly how these proteins spread from cell to cell and damage the brain is not well understood. A new computational mouse model mapped alpha-synuclein, a misfolded protein found in Parkinson’s and related diseases, as it spread through the brain. Described in a study funded in part by NIA and published in Nature Neuroscience, the model is the first to incorporate both brain connectivity and genetic risk factors involved in abnormal alpha-synuclein spread.
READ MORE
University of Miami
What if paralyzed limbs could move using only the power of one’s thoughts? Borrowing a storyline from the realm of science fiction, a team of researchers at The Miami Project to Cure Paralysis — together with neurosurgeons and biomedical engineers from the University of Miami Miller School of Medicine — are using a brain-machine interface to make this once seemingly impossible feat a reality for people who are living with spinal cord injury.
READ MORE
Parkinson's News Today
Researchers have discovered a new enzyme that might aid in “putting the brakes” on Parkinson’s by inhibiting the LRRK2 pathway, known to play a critical role in this neurodegenerative disease.
The findings are still at an early stage, but the team is already trying to find compounds that can switch on this enzyme in the hopes of finding a new therapy that can slow down Parkinson’s disease.
READ MORE
MD Magazine
Despite being a common treatment for high blood pressure and congestive heart failure for decades, new research has uncovered a startling new trend about the use of thiazides in diabetics.
An analysis of data from the ACCORD and ACCORDION studies by a team of investigators from the National Center for Global Health and Medicine in Japan revealed thiazide use was associated with an increased risk of major cardiovascular events, particularly stroke, in type 2 diabetics with well-controlled blood pressure.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
